(en) This editorial refers to ‘A plasma proteogenomic signature for fibromuscular dysplasia’, by J.W. Olin et al., pp. 63–77. After being for long a neglected disease, the last two decades have seen fibromuscular dysplasia (FMD) coming under the spotlight, thanks to novel data from large registries, and more recently from genetic studies, which dramatically changed our knowledge of the disease. [...]
Bruno, R. M., Mischak, H., & Persu, A. (2020). Multi-omics applied to fibromuscular dysplasia: first steps on a new research avenue. Cardiovascular Research, 116(1), 4-5. https://doi.org/10.1093/cvr/cvz307 (Original work published 2020)